Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer. Article uri icon

Overview

publication date

  • August 22, 2011

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Orchiectomy
  • Prostatic Neoplasms

Identity

PubMed Central ID

  • PMC3739559

Scopus Document Identifier

  • 80755127255

Digital Object Identifier (DOI)

  • 10.1038/aja.2011.113

PubMed ID

  • 21857690

Additional Document Info

volume

  • 13

issue

  • 6